EDITORIAL

The National Congress of Oncology

Alexandru Grigorescu

25 Octombrie 2021

The National Congress of Oncology was a scientific event organized by the National Society of Medical Oncology (SNOMR), having a mixed structure: face to face and online. This manifestation helped the PhD students to present the works necessary for the promotion of their doctorate and helped the residents to assert themselves with reviews and case presentations. Some therapeutic behaviors have also been developed. This scientific event did not have the endorsement of a domestic or international medical society, but only the disparate opinions of specialists in medical oncology, surgery and radiotherapy.

The SRROM Congress was an online scientific event that had the endorsement of several oncology societies in Romania, the “Ion Chiricuţă” Institute of Oncology and of the “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca. Important for medical oncology is the fact that this congress was organized under the auspices of the European Society of Medical Oncology (ESMO).

It is a pity that the same oncology pro­­­blems were exposed at an interval of only one week. Given so many presentations that together exceed the time of the ESMO Congress, we would think that many papers are selected in international con­­­gres­ses, but in practice we know that this does not happen very often.

Perhaps it would be useful for one of the congresses to be dedicated more to educa­tional activity and for establishing na­tio­nal therapeutic protocols, and another congress to be dedicated to oncology news and original works. Or maybe we need a unique congress, but we leave this possibility to the readers’ appreciation.

We must mention that these two natio­nal scientific events occurred shortly after the ESMO Congress. In conclusion, I would like to mention the example of ESMO, expressed by President Solange Peters, who said that these meetings of experts constitute a community. If this com­mu­nity can be European or even global, it means that in Romania this could also hap­pen at a national level.

“ESMO Congress 2021: The place where the oncology experts come together, as a community” – Solange Peters.

Articole din ediția curentă

HEMATOLOGIC MALIGNANCY

Leucemie mieloidă acută M1 FAB secundară sindromului mielodisplazic cu exces de blaşti de tip 2

Andreea Neculcea, Iuliana Iordan, Bonea Diana, Mihaela Găman, Ferea Roxana Cătălina , Stejara Nicoleta Mihai, Pîrvan Patricia , Alina Grigoroiu, Onofrei Alexandru , Ion Dumitru, Horia Bumbea, Cristina Mambet, Cristina Enache, Andreea Marinescu, Raluca Nistor, Ana Maria Vlădăreanu
Leucemia acută mieloidă reprezintă o complicaţie evolutivă a sin­dromului mielodisplazic, mai ales în cazul mielodisplaziei cu exc...
HEMATOLOGIC MALIGNANCY

Criza blastică extramedulară în sistemul nervos central – entitate rară în leucemia cronică mieloidă

Ferea Roxana Cătălina , Stejara Nicoleta Mihai, Iuliana Iordan, Mihaela Găman, Pîrvan Patricia , Onofrei Alexandru , Ion Dumitru, Horia Bumbea, Cristina Mambet, Cristina Enache, Andreea Marinescu, Raluca Nistor, Ana Maria Vlădăreanu
Leucemia mieloidă cronică (LMC) este o neoplazie mielo­pro­li­fe­ra­tivă cronică, fiind caracterizată de prezenţa cromozomului Phi...
PALLIATIVE CARE

Îngrijirile paliative – prezent şi viitor

Alexandru Grigorescu
Îngrijirile paliative iau o amploare din ce în ce mai mare în în­trea­ga lume, iar pandemia de COVID-19 a accentuat nevoia pentru astfel de îngrijiri....
Articole din edițiile anterioare

SHORT REVIEW

New approaches to colorectal cancer

Alexandru Grigorescu
Cancerul colonului reprezintă una din cele mai frecvente localizări ale cancerului în epoca noastră....
EDITORIAL

A new achievement of the authors and editors of “Oncolog-Hematolog.ro” journal

Alexandru Grigorescu
I believe that the indexing of the journal Oncolog-Hematolog.ro in Index Copernicus is an event that must be marked in this editorial. This is due to the joint efforts of the authors of the articles and the editor. I will present below the score obtained by our national oncology journal which shows that we ar...
REVIEW

Cardiac toxicity of checkpoint inhibitors (CPI) used in cancer immunotherapy

Alexandru Grigorescu, Mihaela Teodorescu
Acest scurt review analizează câteva studii publicate în ultimii trei ani în întregime pe internet. Am urmărit să extragem prin­ci­pa­le­le caracteristici clinice ale toxicităţii cardiace, alături de principalele investi...